drugset / Trial / NCT00864240

The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

NCT00864240

Phase 1 Completed 15 enrolled Actavis Inc.
RandomizedSingle-groupOpen-labelOther

Summary

To determine the dose-response relationship for Clobex TM (clobetasol propionate) Lotion, 0.05%. This information will be used to estimate the ED50, D1, D2 parameters for use in a full bioequivalence study.

Timeline

Start
2005-10
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 % Topical

Indications

No indication recorded.